- [Home](/) › - [ClinicalTrialStartPulse](/v/clinicaltrialstartpulse) › - [Hubs](/hub/clinicaltrialstartpulse) › - 300+ # ClinicalTrialStartPulse: 300+ **500 clinicalTrialStartPulse: 300+ are listed from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, dated 2026-09-14 to 2026-11-02; the most frequent is AstraZeneca with 22. Data last updated 2026-11-03; each record links to its official source and a full report.** Data as of 2026-11-03 · [Compiled by Zalwin](/research/clinicaltrialstartpulse) from ClinicalTrials.gov (U.S. National Library of Medicine) API v2 Copy citation Download all 500 clinicalTrialStartPulse: 300+ (CSV) — $4.99 → Includes: Sponsor, Phase, Conditions, Enrollment, Countries, Event, Posted, official source URL and score · Card, Apple Pay, Google Pay or Link via Stripe [Free sample: 3 records (CSV)](/v1/verticals/clinicaltrialstartpulse/records.csv?min_enrollment=300) 500 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, dated 2026-09-14 to 2026-11-02. Most frequent: AstraZeneca (22). Each record links to a full report and the official source. Last updated 2026-11-03. Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2. **Search, filter and export ClinicalTrialStartPulse records** [Run instant live search with these filters](/v/clinicaltrialstartpulse?min_enrollment=300&channel=pseo#vt-out) [Download free 3-row sample CSV](/v1/verticals/clinicaltrialstartpulse/records.csv?min_enrollment=300) Unlock the full CSV for these filters — $4.99 → ✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days ## Get new ClinicalTrialStartPulse records by email (free, weekly) We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email. Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe. [See this week's digest](/digest/clinicaltrialstartpulse) Records 500 Most frequent - AstraZeneca (22) - Pfizer (18) - Merck Sharp & Dohme LLC (14) - Janssen Research & Development, LLC (14) - Hoffmann-La Roche (13) ## How do I get new clinicalTrialStartPulse: 300+ by email? Search, filter and export these records, or get alerts when new ones appear. [Search and filter](/v/clinicaltrialstartpulse?min_enrollment=300) [Watch this exact filter](/v/clinicaltrialstartpulse?min_enrollment=300#more-ways) [See alert plans](/v/clinicaltrialstartpulse#pricing) ## What are the top clinicalTrialStartPulse: 300+ right now? | Record | Phase | Conditions | Enrollment | |---|---|---|---| | TriGemX Bio, Inc. | Phase 3 | Migraine | 1500 | | Vertanical GmbH | Phase 3 | Lumbosacral Radiculopathy | 810 | | Guangzhou Patronus Biotech Co., Ltd. | Phase 3 | Respiratory Syncytial Virus (RSV); Respiratory Syncytial Virus (RSV) Infection; RSV Vaccine | 25000 | | Merck Sharp & Dohme LLC | Phase 3 | Small Cell Lung Cancer | 564 | | Keymed Biosciences Co.Ltd | Phase 3 | Multiple Myeloma (MM) | 320 | | AstraZeneca | Phase 3 | Large B-cell Lymphoma | 1200 | | Vaxcyte, Inc. | Phase 3 | Pneumococcal Disease | 1390 | | Genmab | Phase 3 | Head and Neck Squamous Cell Carcinoma | 699 | | AstraZeneca | Phase 2 | Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer; Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer | 477 | | Genmab | Phase 3 | Head and Neck Squamous Cell Carcinoma | 621 | | ArriVent BioPharma, Inc. | Phase 3 | Metastatic Non-Small Cell Lung Cancer; Advanced Non-Small Cell Lung Cancer; EGFR Exon 20 Mutations | 398 | | Bristol-Myers Squibb | Phase 3 | Urothelial Cancer | 1314 | | LuciLab | Phase 3 | Risk Behavior; Cognitive Decline | 368 | | Merck Sharp & Dohme LLC | Phase 3 | Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer | 646 | | EyeBiotech Ltd. | Phase 3 | Diabetic Macular Edema (DME) | 1054 | | Viatris Innovation GmbH | Included in the full CSV with every column 🔒 Unlock all 500 records → | | Viatris Innovation GmbH | Included in the full CSV with every column 🔒 Unlock all 500 records → | | Janssen Research & Development, LLC | Included in the full CSV with every column 🔒 Unlock all 500 records → | Browse 35 more matching record reports - [Viatris Innovation GmbH](/report/clinicaltrialstartpulse/viatris-innovation-gmbh-us--nct-nct05648500-enrollment) - [Viatris Innovation GmbH](/report/clinicaltrialstartpulse/viatris-innovation-gmbh-us--nct-nct05672576-enrollment) - [Janssen Research & Development, LLC](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-nonus--nct-nct07906717) - [Qilu Pharmaceutical Co., Ltd.](/report/clinicaltrialstartpulse/qilu-pharmaceutical-co-ltd-nonus--nct-nct07802821-recruiting) - [Pfizer](/report/clinicaltrialstartpulse/pfizer-us--nct-nct06551324-enrollment) - [BeiGene](/report/clinicaltrialstartpulse/beigene-us--nct-nct05635708-completed) - [Merck Sharp & Dohme LLC](/report/clinicaltrialstartpulse/merck-sharp-and-dohme-llc-us--nct-nct07776691-recruiting) - [Jiangsu Simcere Pharmaceutical Co., Ltd.](/report/clinicaltrialstartpulse/jiangsu-simcere-pharmaceutical-co-ltd-nonus--nct-nct07903701) - [Janssen Research & Development, LLC](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-nonus--nct-nct07903272) - [Jade Biosciences, Inc.](/report/clinicaltrialstartpulse/jade-biosciences-inc-nonus--nct-nct07902817) - [Kite, A Gilead Company](/report/clinicaltrialstartpulse/kite-a-gilead-company-nonus--nct-nct07903506) - [Hoffmann-La Roche](/report/clinicaltrialstartpulse/hoffmann-la-roche-nonus--nct-nct04657289-enrollment) - [Hoffmann-La Roche](/report/clinicaltrialstartpulse/hoffmann-la-roche-us--nct-nct05797610-enrollment) - [BioNTech SE](/report/clinicaltrialstartpulse/biontech-se-us--nct-nct04534205-enrollment) - [Carmot Therapeutics, Inc.](/report/clinicaltrialstartpulse/carmot-therapeutics-inc-us--nct-nct06628362-completed) - [Eli Lilly and Company](/report/clinicaltrialstartpulse/eli-lilly-and-company-us--nct-nct07900633) - [Biohaven Therapeutics Ltd.](/report/clinicaltrialstartpulse/biohaven-therapeutics-ltd-nonus--nct-nct07901244) - [Beijing InnoCare Pharma Tech Co., Ltd.](/report/clinicaltrialstartpulse/beijing-innocare-pharma-tech-co-ltd-nonus--nct-nct07901413) - [CytomX Therapeutics](/report/clinicaltrialstartpulse/cytomx-therapeutics-nonus--nct-nct07900165) - [Shanghai Hengrui Pharmaceutical Co., Ltd.](/report/clinicaltrialstartpulse/shanghai-hengrui-pharmaceutical-co-ltd-nonus--nct-nct07900789) - [AstraZeneca](/report/clinicaltrialstartpulse/astrazeneca-us--nct-nct05138133-enrollment) - [AbbVie](/report/clinicaltrialstartpulse/abbvie-us--nct-nct06602479-enrollment) - [Takeda](/report/clinicaltrialstartpulse/takeda-us--nct-nct02716116-completed) - [Pelage Pharmaceuticals, Inc.](/report/clinicaltrialstartpulse/pelage-pharmaceuticals-inc-us--nct-nct07819435-recruiting) - [Jiangsu Aosaikang Pharmaceutical Co., Ltd.](/report/clinicaltrialstartpulse/jiangsu-aosaikang-pharmaceutical-co-ltd-nonus--nct-nct07897188) - [Jiangsu HengRui Medicine Co., Ltd.](/report/clinicaltrialstartpulse/jiangsu-hengrui-medicine-co-ltd-nonus--nct-nct07790380-recruiting) - [Celltrion](/report/clinicaltrialstartpulse/celltrion-nonus--nct-nct06952478-enrollment) - [Amgen](/report/clinicaltrialstartpulse/amgen-us--nct-nct05581303-enrollment) - [Suzhou Suncadia Biopharmaceuticals Co., Ltd.](/report/clinicaltrialstartpulse/suzhou-suncadia-biopharmaceuticals-co-ltd-nonus--nct-nct07896005) - [RemeGen Co., Ltd.](/report/clinicaltrialstartpulse/remegen-co-ltd-nonus--nct-nct07895355) - [Jiangsu HengRui Medicine Co., Ltd.](/report/clinicaltrialstartpulse/jiangsu-hengrui-medicine-co-ltd-nonus--nct-nct07894328) - [Suzhou Suncadia Biopharmaceuticals Co., Ltd.](/report/clinicaltrialstartpulse/suzhou-suncadia-biopharmaceuticals-co-ltd-nonus--nct-nct07895992) - [Shionogi](/report/clinicaltrialstartpulse/shionogi-us--nct-nct07743580-recruiting) - [Multitude Therapeutics Inc.](/report/clinicaltrialstartpulse/multitude-therapeutics-inc-us--nct-nct07718737-recruiting) - [Hoffmann-La Roche](/report/clinicaltrialstartpulse/hoffmann-la-roche-nonus--nct-nct04712643-enrollment) ## Which related categories and locations should I check? ### Browse by phase [Not applicable (device, behavioral) (4211)](/hub/clinicaltrialstartpulse/phase/na) [Observational (1999)](/hub/clinicaltrialstartpulse/phase/observational) [Phase 2 (1077)](/hub/clinicaltrialstartpulse/phase/phase2) [Phase 3 (559)](/hub/clinicaltrialstartpulse/phase/phase3) [Phase 1 (546)](/hub/clinicaltrialstartpulse/phase/phase1) [Phase 4 (320)](/hub/clinicaltrialstartpulse/phase/phase4) [Early phase 1 (89)](/hub/clinicaltrialstartpulse/phase/early-phase1) ### Browse by site location [Outside the US only (6377)](/hub/clinicaltrialstartpulse/sites/nonus) [United States sites (2424)](/hub/clinicaltrialstartpulse/sites/us) ### Browse by minimum enrollment [100+ (326)](/hub/clinicaltrialstartpulse/min_enrollment/100) [50+ (283)](/hub/clinicaltrialstartpulse/min_enrollment/50) [1,000+ (54)](/hub/clinicaltrialstartpulse/min_enrollment/1000) ## Frequently asked questions ### How many clinicalTrialStartPulse: 300+ are listed? 500 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, last refreshed automatically. The most recent is dated 2026-11-02. ### Can I get alerts for 300+? Yes. ClinicalTrialStartPulse can email you new records matching this filter; plans are listed on the ClinicalTrialStartPulse page. Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2. Informational only. [RSS feed of new records](/feed/clinicaltrialstartpulse.xml) ## Often used together - [NihBiotechGrantPulse](/v/nihbiotechgrantpulse) - [FDAPulse](/v/fdapulse) - [WaLobbyistEmploymentRegistrationsPulse](/v/walobbyistemploymentregistratpulse) - [SecurityIntegratorNdaaAudit](/securityintegratorndaaaudit) - [CoreWebVitalsPulse](/corewebvitalspulse) - [CookieConsentPulse](/cookieconsentpulse)